In T2DM, the dysbiosis of gut microbiome promotes intestinal permeability, LPS translocation, hyperactivation of inflammatory responses and dysregulation of insulin‐related pathways, exacerbating the progression of insulin resistance.34 This evidence concerns the gene INS and Insulin resistance.